Loading…

Host immune system modulation in Ph+ acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab

Saved in:

Bibliographic Details
Published in:	Blood 2021-12, Vol.138 (22), p.2290-2293
Main Authors:	Puzzolo, Maria Cristina, Radice, Giulia, Peragine, Nadia, de Propris, Maria Stefania, Mariglia, Paola, Vignetti, Marco, Vitale, Antonella, Bassan, Renato, Annunziata, Mario, Gaidano, Gianluca, Rambaldi, Alessandro, Chiaretti, Sabina, Guarini, Anna, Foà, Robin
Format:	Article
Language:	English
Subjects:	Adult Antibodies, Bispecific - therapeutic use Antineoplastic Agents, Immunological - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Dasatinib - therapeutic use Humans Immune System - drug effects Immune System - immunology Philadelphia Chromosome Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics Precursor Cell Lymphoblastic Leukemia-Lymphoma - immunology Protein Kinase Inhibitors - therapeutic use
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!